$
18.55
08:09 PM EST
Business Description
Kyorin Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2833
ISIN : JP3247090008
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.92 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 3.37 | |||||
Interest Coverage | 75.18 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.5 | |||||
Beneish M-Score | -2.28 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1 | |||||
3-Year EBITDA Growth Rate | -2.2 | |||||
3-Year EPS without NRI Growth Rate | -13.2 | |||||
3-Year Book Growth Rate | 0.7 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.4 | |||||
Days Inventory | 266.95 | |||||
Days Sales Outstanding | 131.76 | |||||
Days Payable | 69.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -11.5 | |||||
Shareholder Yield % | 3.16 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.92 | |||||
Operating Margin % | 4.08 | |||||
Net Margin % | 3.56 | |||||
FCF Margin % | -6.52 | |||||
ROE % | 3.38 | |||||
ROA % | 2.43 | |||||
ROIC % | 2.42 | |||||
ROC (Joel Greenblatt) % | 6.18 | |||||
ROCE % | 4.43 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 23.93 | |||||
PE Ratio without NRI | 26.42 | |||||
Shiller PE Ratio | 14.94 | |||||
PS Ratio | 0.85 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 0.84 | |||||
Price-to-Operating-Cash-Flow | 50.71 | |||||
EV-to-EBIT | 16.8 | |||||
EV-to-EBITDA | 16.8 | |||||
EV-to-Revenue | 0.86 | |||||
EV-to-FCF | -13.99 | |||||
Price-to-Projected-FCF | 0.82 | |||||
Price-to-Median-PS-Value | 0.67 | |||||
Price-to-Graham-Number | 0.99 | |||||
Price-to-Net-Current-Asset-Value | 1.49 | |||||
Earnings Yield (Greenblatt) % | 5.95 | |||||
FCF Yield % | -7.26 | |||||
Forward Rate of Return (Yacktman) % | 0.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KYRNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kyorin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 848.392 | ||
EPS (TTM) ($) | 0.517 | ||
Beta | -0.01 | ||
Volatility % | 1.29 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 18.55 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 18.55 - 18.55 | ||
Shares Outstanding (Mil) | 57.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kyorin Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kyorin Pharmaceutical Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kyorin Pharmaceutical Co Ltd Frequently Asked Questions
What is Kyorin Pharmaceutical Co Ltd(KYRNF)'s stock price today?
When is next earnings date of Kyorin Pharmaceutical Co Ltd(KYRNF)?
Does Kyorin Pharmaceutical Co Ltd(KYRNF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |